Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, J.
Right arrow Articles by He, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, J.
Right arrow Articles by He, J.
J Am Soc Nephrol 14:469-477, 2003
© 2003 American Society of Nephrology

Insulin Resistance and Risk of Chronic Kidney Disease in Nondiabetic US Adults

Jing Chen*, Paul Muntner*,{dagger}, L. Lee Hamm*, Vivian Fonseca*, Vecihi Batuman*, Paul K. Whelton*,{dagger} and Jiang He*,{dagger}

*Tulane University School of Medicine and {dagger}School of Public Health and Tropical Medicine, New Orleans, Louisiana.

Correspondence to Dr. Jiang He, Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, 1430 Tulane Avenue SL18. Phone: 504-588-5165; Fax: 504-988-1568;

ABSTRACT. This study examined the relationship of fasting serum glucose, insulin, C-peptide, glycosylated hemoglobin A (HbA1c), and Homeostasis Model Assessment (HOMA)-insulin resistance to risk of chronic kidney disease (CKD) among 6453 persons without diabetes (fasting glucose <126 mg/dl and not taking diabetes medication) who participated in the Third National Health and Nutrition Examination Survey and were aged 20 yr or older. CKD was defined as an estimated GFR <60 ml/min per 1.73 m2. The prevalence of CKD was significantly and progressively higher with increasing levels of serum insulin, C-peptide, HbA1c, and HOMA-insulin resistance. After adjustment for potential confounding variables, the odds ratio of CKD for the highest compared with the lowest quartile was 4.03 (95% confidence interval [CI], 1.81 to 8.95; P = 0.001), 11.4 (95% CI, 4.07 to 32.1; P < 0.001), 2.67 (95% CI, 1.31 to 5.46; P = 0.002), and 2.65 (95% CI, 1.25 to 5.62; P = 0.008) for serum insulin, C-peptide, HbA1c levels, and HOMA-insulin resistance, respectively. For a one SD higher level of serum insulin (7.14 µU/ml), C-peptide (0.45 {Delta}mol/ml), HbA1c (0.52%), and HOMA-insulin resistance (1.93), the odds ratio (95% CI) of CKD was 1.35 (1.16 to 1.57), 2.78 (2.25 to 3.42), 1.69 (1.28 to 2.23), and 1.30 (1.13 to 1.50), respectively. These findings combined with knowledge from previous studies suggest that the insulin resistance and concomitant hyperinsulinemia are presented in CKD patients without clinical diabetes. Further studies into the causality between insulin resistance and CKD are warranted. E-mail address: jhe@tulane.edu




This article has been cited by other articles:


Home page
CJASNHome page
S. Kobayashi, M. Oka, K. Maesato, R. Ikee, T. Mano, M. Hidekazu, and T. Ohtake
Coronary Artery Calcification, ADMA, and Insulin Resistance in CKD Patients
Clin. J. Am. Soc. Nephrol., September 1, 2008; 3(5): 1289 - 1295.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
E. Nerpin, U. Riserus, E. Ingelsson, J. Sundstrom, M. Jobs, A. Larsson, S. Basu, and J. Arnlov
Insulin Sensitivity Measured With Euglycemic Clamp Is Independently Associated With Glomerular Filtration Rate in a Community-Based Cohort
Diabetes Care, August 1, 2008; 31(8): 1550 - 1555.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. Shankar, C. Leng, K. S. Chia, D. Koh, E. S. Tai, S. M. Saw, S. C. Lim, and T. Y. Wong
Association between body mass index and chronic kidney disease in men and women: population-based study of Malay adults in Singapore
Nephrol. Dial. Transplant., June 1, 2008; 23(6): 1910 - 1918.
[Abstract] [Full Text] [PDF]


Home page
Age AgeingHome page
M. Kanauchi, K. Kanauchi, T. Inoue, K. Kimura, and Y. Saito
Insulin sensitivity and beta-cell function in older Japanese adults without diabetes
Age Ageing, May 1, 2008; 37(3): 330 - 333.
[Full Text] [PDF]


Home page
CJASNHome page
C. Lorenzo, S. D. Nath, A. J.G. Hanley, H. E. Abboud, and S. M. Haffner
Relation of Low Glomerular Filtration Rate to Metabolic Disorders in Individuals without Diabetes and with Normoalbuminuria
Clin. J. Am. Soc. Nephrol., May 1, 2008; 3(3): 783 - 789.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
H. K. Choi and E. S. Ford
Haemoglobin A1c, fasting glucose, serum C-peptide and insulin resistance in relation to serum uric acid levels--the Third National Health and Nutrition Examination Survey
Rheumatology, May 1, 2008; 47(5): 713 - 717.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M L. Trirogoff, A. Shintani, J. Himmelfarb, and T A. Ikizler
Body mass index and fat mass are the primary correlates of insulin resistance in nondiabetic stage 3 4 chronic kidney disease patients
Am. J. Clinical Nutrition, December 1, 2007; 86(6): 1642 - 1648.
[Abstract] [Full Text] [PDF]


Home page
Ther Adv Cardiovasc DisHome page
A. Whaley-Connell, B. S. Pavey, K. Chaudhary, G. Saab, and J. R. Sowers
Review: Renin-angiotensin-aldosterone system intervention in the cardiometabolic syndrome and cardio-renal protection
Therapeutic Advances in Cardiovascular Disease, October 1, 2007; 1(1): 27 - 35.
[Abstract] [PDF]


Home page
CJASNHome page
A. Rashidi, A. Ghanbarian, and F. Azizi
Are Patients Who Have Metabolic Syndrome without Diabetes at Risk for Developing Chronic Kidney Disease? Evidence Based on Data from a Large Cohort Screening Population
Clin. J. Am. Soc. Nephrol., September 1, 2007; 2(5): 976 - 983.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
E. Ritz
Metabolic Syndrome: An Emerging Threat to Renal Function
Clin. J. Am. Soc. Nephrol., September 1, 2007; 2(5): 869 - 871.
[Full Text] [PDF]


Home page
Diabetes CareHome page
M. F. Crutchlow, B. Robinson, B. Pappachen, N. Wimmer, A. J. Cucchiara, D. Cohen, and R. Townsend
Validation of Steady-State Insulin Sensitivity Indices in Chronic Kidney Disease
Diabetes Care, July 1, 2007; 30(7): 1813 - 1818.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
L. H. Oterdoom, A. P. J. de Vries, R. T. Gansevoort, P. E. de Jong, R. O. B. Gans, S. J. L. Bakker, and for the PREVEND Study Group
Fasting insulin modifies the relation between age and renal function
Nephrol. Dial. Transplant., June 1, 2007; 22(6): 1587 - 1592.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
I. M. Wahba and R. H. Mak
Obesity and Obesity-Initiated Metabolic Syndrome: Mechanistic Links to Chronic Kidney Disease
Clin. J. Am. Soc. Nephrol., May 1, 2007; 2(3): 550 - 562.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
K. Kaartinen, J. Syrjanen, I. Porsti, A. Harmoinen, A. Pasternack, H. Huhtala, O. Niemela, and J. Mustonen
Insulin resistance and the progression of IgA glomerulonephritis
Nephrol. Dial. Transplant., March 1, 2007; 22(3): 778 - 783.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
T. S. Perlstein, M. Gerhard-Herman, N. K. Hollenberg, G. H. Williams, and A. Thomas
Insulin Induces Renal Vasodilation, Increases Plasma Renin Activity, and Sensitizes the Renal Vasculature to Angiotensin Receptor Blockade in Healthy Subjects
J. Am. Soc. Nephrol., March 1, 2007; 18(3): 944 - 951.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
S. Ryu, Y. Chang, D.-I. Kim, W. S. Kim, and B.-S. Suh
{gamma}-Glutamyltransferase as a Predictor of Chronic Kidney Disease in Nonhypertensive and Nondiabetic Korean Men
Clin. Chem., January 1, 2007; 53(1): 71 - 77.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
M. Kanauchi, K. Kanauchi, K. Kimura, T. Inoue, and Y. Saito
Associations of chronic kidney disease with the metabolic syndrome in non-diabetic elderly
Nephrol. Dial. Transplant., December 1, 2006; 21(12): 3608 - 3609.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. G. de Vinuesa, M. Goicoechea, J. Kanter, M. Puerta, V. Cachofeiro, V. Lahera, F. Gomez-Campdera, and J. Luno
Insulin Resistance, Inflammatory Biomarkers, and Adipokines in Patients with Chronic Kidney Disease: Effects of Angiotensin II Blockade
J. Am. Soc. Nephrol., December 1, 2006; 17(12_suppl_3): S206 - S212.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
L. F. Fried, R. Katz, M. J. Sarnak, M. G. Shlipak, P. H.M. Chaves, N. S. Jenny, C. Stehman-Breen, D. Gillen, A. J. Bleyer, C. Hirsch, et al.
Kidney Function as a Predictor of Noncardiovascular Mortality
J. Am. Soc. Nephrol., December 1, 2005; 16(12): 3728 - 3735.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
C. S. Fox, M. G. Larson, E. P. Leip, J. B. Meigs, P. W.F. Wilson, and D. Levy
Glycemic Status and Development of Kidney Disease: The Framingham Heart Study
Diabetes Care, October 1, 2005; 28(10): 2436 - 2440.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
H. Kramer and M. E. Molitch
Screening for Kidney Disease in Adults With Diabetes
Diabetes Care, July 1, 2005; 28(7): 1813 - 1816.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. Kurella, J. C. Lo, and G. M. Chertow
Metabolic Syndrome and the Risk for Chronic Kidney Disease among Nondiabetic Adults
J. Am. Soc. Nephrol., July 1, 2005; 16(7): 2134 - 2140.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. R. Sedor and J. R. Schelling
Association of Metabolic Syndrome in Nondiabetic Patients with Increased Risk for Chronic Kidney Disease: The Fat Lady Sings
J. Am. Soc. Nephrol., July 1, 2005; 16(7): 1880 - 1882.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
B. Becker, F. Kronenberg, J. T. Kielstein, H. Haller, C. Morath, E. Ritz, D. Fliser, and for the MMKD Study Group
Renal Insulin Resistance Syndrome, Adiponectin and Cardiovascular Events in Patients with Kidney Disease: The Mild and Moderate Kidney Disease Study
J. Am. Soc. Nephrol., April 1, 2005; 16(4): 1091 - 1098.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
T. Lau, P.-O. Carlsson, P.S. Leung, C. Wolfrum, E. Asilmaz, E. Luca, J.M. Friedman, M. Stoffel, J.C. Verhave, H.L. Hillege, et al.
Why Less Diabetes with Blockade of the Renin-Angiotensin System?: Evidence for a Local Angiotensin-Generating System and Dose-Dependent Inhibition of Glucose-Stimulated Insulin Release by Angiotensin II in Isolated Pancreatic Islets. Diabetologia 47: 240-248, 2004
J. Am. Soc. Nephrol., March 1, 2005; 16(3): 567 - 573.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. P. Bagby
Obesity-Initiated Metabolic Syndrome and the Kidney: A Recipe for Chronic Kidney Disease?
J. Am. Soc. Nephrol., November 1, 2004; 15(11): 2775 - 2791.
[Full Text] [PDF]


Home page
ANN INTERN MEDHome page
J. Chen, P. Muntner, L. L. Hamm, D. W. Jones, V. Batuman, V. Fonseca, P. K. Whelton, and J. He
The Metabolic Syndrome and Chronic Kidney Disease in U.S. Adults
Ann Intern Med, February 3, 2004; 140(3): 167 - 174.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
E Ritz
Minor renal dysfunction: an emerging independent cardiovascular risk factor
Heart, September 1, 2003; 89(9): 963 - 964.
[Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP